The U.S. and Europe have shifted their focus toward booster doses, which have been proven critical in protection against omicron. As omicron lays the enduring threat from a mutating coronavirus and new variants, learn the latest developments in the COVID-19 vaccine.
INCLUDED IN THIS TRENDLINE
- Moderna to seek clearance for COVID-19 vaccine in young children
- Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill
- Pfizer, Moderna sued over technology used in COVID vaccines